Stay updated on Belantamab Mafodotin Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin Combo in Myeloma Clinical Trial page.

Latest updates to the Belantamab Mafodotin Combo in Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe DREAMM 9 record now lists a second results submission event, indicating additional results-reporting activity. An NIH notice about the transition from “AI” to “SI” also appears.SummaryDifference0.5%

- Check8 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the study record information remains unchanged.SummaryDifference0.1%

- Check15 days agoChange DetectedThe footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision entry (v3.7.0) has been added to the record history, replacing the previous revision (v3.6.6). This signals an update to the page history, typically reflecting refreshed or corrected content in the study record.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page history now shows a new revision entry v3.6.6 and removes the previous v3.6.5, indicating an update to the page's revision history.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the Study Record History, replacing the previous 'Revision: v3.6.4'. This indicates an updated version of the study record in ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to Belantamab Mafodotin Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin Combo in Myeloma Clinical Trial page.